Search This Blog

Thursday, November 7, 2019

Nevro up 22% on Q3 beat, revenue guidance boost

Nevro (NVRO +22.3%) is up on double normal volume on the heels of its Q3 results released after the close yesterday. Highlights:
Revenue: $100.2M (+5%).
Net loss: ($17.6M) (-57%); loss/share: ($0.58) (-57%).
Non-GAAP EBITDA: ($2.0M) (-139%).
Senza Omnia SCS device launched yesterday.
CFO Andrew Galligan to retire.
2019 guidance: Revenue: $383M – 386M from $368M – 374M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.